1090 related articles for article (PubMed ID: 15922819)
81. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
[TBL] [Abstract][Full Text] [Related]
82. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.
Brunet M; Cirera I; Martorell J; Vidal E; Millán O; Jiménez O; Rojo I; Londoño MC; Rimola A
Transplantation; 2006 Feb; 81(4):541-6. PubMed ID: 16495801
[TBL] [Abstract][Full Text] [Related]
83. The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation.
Borrows R; Chusney G; Loucaidou M; James A; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Ther Drug Monit; 2007 Feb; 29(1):122-6. PubMed ID: 17304160
[TBL] [Abstract][Full Text] [Related]
84. Determinants of mycophenolic acid levels after renal transplantation.
Borrows R; Chusney G; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Ther Drug Monit; 2005 Aug; 27(4):442-50. PubMed ID: 16044100
[TBL] [Abstract][Full Text] [Related]
85. Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation.
Kim H; Yi NJ; Lee J; Kim J; Moon MR; Jeong J; Lee JM; You TS; Suh SW; Park MS; Choi Y; Hong G; Lee HW; Lee KW; Suh KS
Clin Mol Hepatol; 2014 Sep; 20(3):291-9. PubMed ID: 25320733
[TBL] [Abstract][Full Text] [Related]
86. A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.
Alvarez-Elías AC; Yoo EC; Todorova EK; Singh RN; Filler G
Ther Drug Monit; 2017 Jun; 39(3):220-228. PubMed ID: 28437284
[TBL] [Abstract][Full Text] [Related]
87. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
[TBL] [Abstract][Full Text] [Related]
88. The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial.
Mudge DW; Atcheson B; Taylor PJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Nicol DL; Pillans PI; Johnson DW
Transplantation; 2004 Jan; 77(2):206-9. PubMed ID: 14742982
[TBL] [Abstract][Full Text] [Related]
89. Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil.
Jain A; Venkataramanan R; Kwong T; Mohanka R; Orloff M; Abt P; Kashyap R; Tsoulfas G; Mack C; Williamson M; Batzold P; Bozorgzadeh A
Liver Transpl; 2007 Jun; 13(6):791-6. PubMed ID: 17538999
[TBL] [Abstract][Full Text] [Related]
90. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
91. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G
Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
[TBL] [Abstract][Full Text] [Related]
92. Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation.
Filler G
Pediatr Transplant; 2006 Sep; 10(6):707-11. PubMed ID: 16911495
[TBL] [Abstract][Full Text] [Related]
93. Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2009 Aug; 31(4):467-74. PubMed ID: 19571775
[TBL] [Abstract][Full Text] [Related]
94. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.
Greanya ED; Poulin E; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Am J Health Syst Pharm; 2012 Jan; 69(2):134-42. PubMed ID: 22215359
[TBL] [Abstract][Full Text] [Related]
95. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
[TBL] [Abstract][Full Text] [Related]
96. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
97. Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.
van Hest RM; Mathot RA; Vulto AG; Ijzermans JN; van Gelder T
Ther Drug Monit; 2006 Feb; 28(1):31-4. PubMed ID: 16418690
[TBL] [Abstract][Full Text] [Related]
98. Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.
Maiguma T; Yosida T; Otsubo K; Okabe Y; Sugitani A; Tanaka M; Oishi R; Teshima D
J Clin Pharm Ther; 2010 Feb; 35(1):79-85. PubMed ID: 20175815
[TBL] [Abstract][Full Text] [Related]
99. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience.
Zakliczyński M; Szewczyk M; Zakliczyńska H; Zembala M
Ann Transplant; 2005; 10(2):38-45. PubMed ID: 16218032
[TBL] [Abstract][Full Text] [Related]
100. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?
Cox VC; Ensom MH
Ther Drug Monit; 2003 Apr; 25(2):137-57. PubMed ID: 12657908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
